TNFSF11 and metastasis: NF-κB activation is triggered by different extracellular stimuli such as inflammatory cytokines, EGF or RANKL [14], [15], [16], [17], a finding that is the base for using antibodies against TNFα, soluble TNFα receptors or RANKL inhibitors in patients with bone-metastasis [18], [19].